Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

    This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: January 7, 2027 (Current closing date)

    Funding Amounts: No budget cap; requests must reflect project needs; maximum project period of 5 years

    Summary: Supports investigator-initiated clinical trials to reduce cancer burden through prevention, early detection, screening, healthcare delivery, survivorship, and quality-of-life improvements.

    Key Information: NIH-defined clinical trials are required; cancer diagnosis and oncologic treatment trials are not supported.


    Description

    The National Cancer Institute (NCI) offers this R01 program for investigator-initiated Phase 0–IV clinical trials aligned with its Division of Cancer Prevention or Division of Cancer Control and Population Sciences. Studies should reduce the burden of cancer and have potential to improve clinical practice or public health.

    Relevant work includes cancer prevention and interception, screening, early detection biomarkers, behavioral interventions, cancer susceptibility, implementation science, healthcare delivery, survivorship, supportive and palliative care, and quality of life. Trials may address burdens experienced by patients, survivors, families, and caregivers. Applications may combine clinical trials with other research aims and include correlative laboratory or imaging endpoints. Observational-only studies and trials focused on cancer diagnosis or oncologic treatment are outside this program’s scope.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.